Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, July 21, 2010
Tue, July 20, 2010 FBP, NEXM, MSOA Have Been Added To Naked Short Lists Today
July 20, 2010 /M2 PRESSWIRE/ BUYINS.NET, www.buyins.net, announced today that these select companies have been added to the NASDAQ, AMEX and NYSE naked short threshold lists. First Bancorp (NYSE: FBP), NexMed (NASDAQ: NEXM) and My Social Income (OTC: MSOA). For a complete list of companies on the naked short lists please visit our web site. To find the SqueezeTrigger Price before a short squeeze starts in any stock, go to http://www.buyins.net .
First BanCorp (NYSE: FBP) operates as the holding company for FirstBank Puerto Rico that provides a range of financial services and products to retail, commercial, and institutional clients in Puerto Rico, the United States, and the British Virgin Islands. The company offers various deposit products, such as interest-bearing and non-interest bearing checking and savings accounts; individual retirement accounts; and retail certificates of deposit. It also provides commercial loans, including commercial real estate and construction loans; and auto, boat, personal, small loans, as well as lines of credit. In addition, the company involves in the origination, sale, and servicing of various residential mortgage loan products. Further, it offers cash management and business management services. Additionally, the company offers vehicle leasing, insurance agency, municipal bond underwriting, financial advisory, international banking, finance lease, and broker-dealer services. As of February 1, 2010, it operated 186 branches, stand-alone offices, and in-branch service centers. First BanCorp was founded in 1948 and is headquartered in San Juan, Puerto Rico. There is a failure to deliver in shares of FBP.
NexMed, Inc. (NASDAQ: NEXM) engages in designing and developing pharmaceutical products based on its patented NexACT drug delivery technology. The NexACT drug delivery technology is designed to enhance the delivery of an active drug to improve therapeutic outcomes and reduce systemic side effects that accompany oral and injectable medications. The companya�s proprietary topical nail solution, NM100060, is a Phase III clinical trial product for the treatment of onychomycosis (nail fungal infection). Its products also include Vitaros, a Phase III clinical trial topical alprostadil-based cream treatment for patients with erectile dysfunction; and Femprox, a Phase II clinical trial alprostadil-based cream product for the treatment of female sexual arousal disorder. In addition, NexMed focuses on developing treatments for psoriasis, cancer inflammation, pain, and wound healing. Further, the company, through its subsidiary, Bio-Quant, Inc., operates as a specialty biotech contract research organization that provides services in the areas of non-good laboratory practices in vitro and in vivo contract drug discovery, as well as pre-clinical development services specializing in oncology, inflammation, immunology, and metabolic diseases. Bio-Quant, Inc. also conducts studies in the areas of in vitro and in vivo pharmacology, pharmacokinetics, and toxicology to support pre-investigational new drug enabling packages, as well as sells diagnostic kits. The company was founded in 1987 and is headquartered in San Diego, California. There is a failure to deliver in shares of NEXM.
My Social Income, Inc. (OTC: MSOA) provides voice over Internet protocol services to wireless and wireline broadband customers. It offers CoIP programs, including MSI Connect, a portable prepaid calling account; MSI PSTN Connect, which connects the public network to the user with associated DID number; MSI Broadband Connect, a local phone service/long distance package for residential customers with broadband Internet service; and Send-a-Call, a prepaid calling account. The company markets its products directly, as well as through call centers and affiliate groups. My Social Income, Inc. was formerly known as InteleCom, Inc. The company was founded in 1997 and is based in Indianapolis, Indiana. There is a failure to deliver in shares of MSOA.
BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.
INVESTMENTS & TRADING
SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
About BUYINS.NET
WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.
BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database of nearly 2,750,000,000 short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money.
All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET may receive compensation in cash or shares from independent third parties or from the companies mentioned.
BUYINS.NET affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. Market commentary provided by Thomas Ronk.
BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.
You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.
Contact: Thomas Ronk / CEO www.BUYINS.net (800) 715-9999 tom@buyins.net
- WOPRAI
- support@woprai.com